Clinical Trial Update: Orodispersible Minitablets of Enalapril in Young Children With Heart Failure Due to Congenital Heart Disease [Phase 2, Phase 3]

View source ↗

Summary

Clinical trial update for a Phase 2/3 study of orodispersible minitablets of enalapril in young children with heart failure due to congenital heart disease.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Congenital Heart Disease
• Heart Failure

Drugs mentioned

• Enalapril (enalapril)

Snippet

Sponsor: Ethicare GmbH | Conditions: Heart Failure, Congenital Heart Disease | Phase 2, Phase 3 | Status: UNKNOWN